A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology (original) (raw)

References

• Albert H, Dale EC, Lee E, Ow DW . (1995). Plant J 7: 649–659.
• Alizadeh AA, Ross DT, Perou CM, van de Rijn M . (2001). J Pathol 195: 41–52.
• Chang CP, Jacobs Y, Nakamura T, Jenkins NA, Copeland NG, Cleary ML . (1997). Mol Cell Biol 17: 5679–5687.
• Christiansen DH, Pedersen-Bjergaard J . (2001). Leukemia 15: 1848–1851.
• Cleary ML . (1991). Cell 66: 619–622.
• Codrington R, Pannell R, Forster A, Drynan LF, Daser A, Lobato MN et al. (2005). Publ Lib Sci Biol 3: e242.
• Collins EC, Pannell R, Simpson EM, Forster A, Rabbitts TH . (2000). EMBO R 1: 127–132.
• Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA et al. (1996). Cell 85: 853–861.
• Daser A, Rabbitts TH . (2004). Genes Dev 18: 965–974.
• DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML . (2002). Blood 99: 3780–3785.
• DiMartino JF, Miller T, Ayton PM, Landewe T, Hess JL, Cleary ML et al. (2000). Blood 96: 3887–3893.
• Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, Corral J et al. (1999). EMBO J 18: 3564–3574.
• Dobson CL, Warren AJ, Pannell R, Forster A, Rabbitts TH . (2000). EMBO J 19: 843–851.
• Drynan LF, Pannell R, Forster A, Chan NMM, Cano F, Daser A et al. (2005). EMBO J 24: 3136–3146.
• Forster A, Pannell R, Drynan LF, Codrington R, Daser A, Metzler M et al. (2005). Nat Methods 2: 27–30.
• Forster A, Pannell R, Drynan LF, McCormack M, Collins EC, Daser A et al. (2003). Cancer Cell 3: 449–458.
• Greaves MF, Maia AT, Wiemels JL, Ford AM . (2003). Blood 102: 2321–2333.
• Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh EJ, Downing JR . (2002). Cancer Cell 1: 63–74.
• Hoess RH, Ziese M, Sternberg N . (1982). Proc Natl Acad Sci USA 79: 3398–3402.
• Hotfilder M, Rottgers S, Rosemann A, Schrauder A, Schrappe M, Pieters R et al. (2005). Cancer Res 65: 1442–1449.
• Jamal R, Taketani T, Taki T, Bessho F, Hongo T, Hamaguchi H et al. (2001). Genes Chromosomes Cancer 31: 187–190.
• Lavau C, Luo RT, Du C, Thirman MJ . (2000). Proc Natl Acad Sci USA 97: 10984–10989.
• Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D et al. (2003). Cancer Cell 4: 197–207.
• McCormack MP, Forster A, Drynan LF, Pannell R, Rabbitts TH . (2003). Mol Cell Biol 23: 9003–9013.
• Mombaerts P, Iancomini J, Johnson RS, Herrup K, TRonegawa S, Papaloannou VE . (1992). Cell 68: 869–877.
• Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C et al. (2002). Proc Natl Acad Sci USA 99: 8242–8247.
• Morse III HC, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL et al. (2002). Blood 100: 246–258.
• Nakamura T, Jenkins NA, Copeland NG . (1996). Oncogene 13: 2235–2242.
• Nam CH, Rabbitts TH . (2006). Mol Ther 13: 15–25.
• Peham M, Panzer S, Fasching K, Haas OA, Fischer S, Marschalek R et al. (2002). Br J Haematol 117: 315–321.
• Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. (2002). Lancet 359: 1909–1915.
• Rabbitts TH . (1991). Cell 67: 641–644.
• Rabbitts TH . (1994). Nature 372: 143–149.
• Rubnitz JE, Morrissey J, Savage PA, Cleary ML . (1994). Blood 84: 1747–1752.
• Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC et al. (2002). Nat Med 8: 68–74.
• Slany RK, Lavau C, Cleary ML . (1998). Mol Cell Biol 18: 122–129.
• So CW, Lin M, Ayton PM, Chen EH, Cleary ML . (2003). Cancer Cell 4: 99–110.
• Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM et al. (2001). BMC Dev Biol 1: 4.
• Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM . (2003). Proc Natl Acad Sci USA 100: 9991–9996.

Download references